期刊文献+

甲状腺乳头状癌原发灶外科治疗的Meta分析 被引量:13

Surgical treatment for primary papillary thyroid cancer:a Meta-analysis
原文传递
导出
摘要 目的:采用Meta分析的方法,比较甲状腺全切术(TT)和甲状腺部分切术(PT)治疗甲状腺乳头状癌患者的疗效,为临床手术方式的选择提供循证学依据。方法:严格制定纳入排除标准,采用机检和手工检索相结合,系统全面检索CNKI、万方和PubMed、central、CBM等数据库比较甲状腺全切术和甲状腺部分切术治疗甲状腺乳头状癌患者的相关文献,检索时间截止2013年12月31日。结果:按照检索策略进行文献检索,检索到相关文献4 630篇,符合纳入排除标准的文献共20篇,均为回顾性研究。喉返神经损伤率TT组、PT组分别为5.9%、2.0%[OR=0.39,95%CI(0.17∽0.90),P〈0.05];甲状旁腺损伤率TT组、PT组分别为4.9%、0.8%[OR=0.23,95%CI(0.08∽0.68),P〈0.01];10年生存率TT组、PT组分别为95.2%∽100.0%、96.8%∽99.2%[OR=0.03,95%CI(0∽0.34)];未分期、未分组TT组、PT组术后复发率为4.7%、12.6%[OR=3.21,95%CI(1.57∽6.57),P〈0.01];Ⅰ期TT组、PT组术后复发率为4.9%、7.8%[OR=3.82,95%CI(1.07∽13.66),P〈0.05];Ⅱ期患者TT组、PT组术后复发率为0.5%、15.9%[OR=17.23,95%CI(4.03∽73.73),P〈0.01]。结论:甲状腺乳头状癌原发灶外科治疗术后均可取得较好的生存率,但甲状腺部分切除术喉返神经及甲状旁腺损伤率低。因此,甲状腺部分切除应该是相对早期甲状腺乳头状癌的较好选择;相对晚期的甲状腺乳头状癌可以选择甲状腺全切除术。 Objective:To assess and compare the two procedures, total thyroidectomy (TT) and partial thy- roidectomy (PT), for papillary thyroid cancer in terms of associated injuries, postoperative complication, recur- rence rate and survival, so as to provide a reference and basis for surgical procedure option of this disease. Method: Strictly specified into the exclusion criteria, the combination of computer retrieval and manual retrieval and retrieval systems such as CNKI, Wang Fan, PubMed, central, CBM database. Total thyroidectomy and partial thyroidectomy for the treatment of patients with thyroid papillary cancer related literature were compared,with the retrieval time until December 31,2013. Result: According to the retrieval strategy 4630 literatures were found, and 20 witch matched the exclusion criteria were left, all were retrospective study. TT and PT group of recurrent laryngeal nerve injury rate are 5.9%, 2.0% respectively [OR=0.39,95%CI (0.17--0.90),P〈0.05], TT and PT group of parathyroid injury rate are respectively 4.9 %, 0.8% respectively [ OR = O. 23,95% C I ( 0. 08 -- 0. 68), P 0.01]. The TT group of 10 years survival rate is 95.24%--100% ,and the PT group is 96.8% --99.2% [OR= 0.03,95 %CI (0-0. 34), P〈0.01]. Unstaged, unstaged TT groupp postoperative recurrence rate is 4.70%, while PT group is 12.6%01OR=3.21,95%CI(1.57-6.57),P〈0.01]. Postoperative recurrence of stage ]- TT group and PT group are 4.9%,7.8% respectively [-OR:3.82,95%CI (1.07--13.66),P〈0.05];The rate of stage Ⅱ TT group is 0.5% ,while the rate of PT group is 15.9%[0R=17.23,95%CI (4.03--73.73) ,P〈0. 01]. Conclu- sion:Different methods of primary thyroid papillary carcinoma surgical treatment can all obtaina good survival,but the rate of laryngeal recurrent nerve injury and parathyroid injury caused by partal throidectomy is relatively lower. As a result, partial thyroidectomy can be a good choice for early stage thyroid papillary carcinoma.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2015年第9期835-840,共6页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 甲状腺乳头状癌 生存率 并发症 甲状腺切除术 META分析 papillary thyroid neoplasms survival rate complication thyroidectomy~ Meta-analysis
  • 相关文献

参考文献16

二级参考文献62

  • 1ZHURui-sen YUYong-li LUHan-kui LUOQuan-yong CHENLi-bo.Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of ^(131)I[J].Chinese Medical Journal,2005(5):425-428. 被引量:10
  • 2Roh JL,Park JY,Park CI.Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients:pattern of nodal metastasis,morbidity,recurrence,and postoperative levels of serum parathyroid hormone[J].Ann Surg,2007,245:604-610.
  • 3Leboulleux S,Rubino C,Baudin E,et al.Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis[J].J Clin Endocrinol Metab,2005,90:5723-5729.
  • 4Heinrich S,Schafer M,Rousson V,et al.Evidence-based treatment of acute pancreatitis:a look at established paradigms[J].Ann Surg,2006,243:154-168.
  • 5Henry JF,Gramatica L,Denizot A,et al.Morbidity of prophylactic lymph nodedissection in the central neck area in patients with papillary thyroid carcinoma[J].Langenbecks Arch Surg,1998,383:167-169.
  • 6Palestini N,Borasi A,Cestino L,et al.Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer Our experience[J].Langenbecks Arch Surg,2008,393:693-698.
  • 7Sywak M,Cornford L,Roach P,et al.Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer[J].Surgery,2006,140:1000-1005; discussion 1005-1007.
  • 8Cooper DS,Doherty GM,Haugen BR,et al.Management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J].Thyroid,2006,16:109-142.
  • 9Arturi F,Russo D,Giuffrida D,et al.Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes[J].J Clin Endocrinol Metab,1997,82:1638-1641.
  • 10Roh JL,Kim JM,Park CI.Lateral cervical lymph node metastases from papillary thyroid carcinoma:pattern of nodal metastases and optimal strategy for neck dissection[J].Ann Surg Oncol,2008,15:1177-1182.

共引文献814

同被引文献73

  • 1屈兵,姚磊,周珞华.桥本亚甲状腺炎并甲状腺非何杰金淋巴瘤1例报告[J].中国实用外科杂志,2013,33(S1):73-73. 被引量:2
  • 2温济民.喉返神经显露在甲状腺手术中的意义[J].中国地方病学杂志,2006,25(3):253-253. 被引量:1
  • 3滕晓春,滕笛,单忠艳,关海霞,李玉姝,于晓会,范晨玲,崇巍,杨帆,何力,刘华,温松臣,戴红,毛金媛,谷晓岚,于扬,李佳,陈彦彦,赵冬,杨榕,姜雅秋,李晨阳,滕卫平.碘摄入量增加对甲状腺疾病影响的五年前瞻性流行病学研究[J].中华内分泌代谢杂志,2006,22(6):512-517. 被引量:135
  • 4托尔宾.弗拉季斯拉夫.费达罗维奇.乌克兰居民在切尔诺贝利核电站事故后的健康状况[J].解放军医学杂志,2007,32(7):761-764. 被引量:4
  • 5Orsenigo E. Beretta E, Fiacco E, et al. Management of papillary micro- carcinoma of the thyroid gland [ J ]. Eur J Surg Oncol,2004,30 ( 10 ) ; 1104-1106.
  • 6Kwait JY, Kim EK, Kim MJ, et al, Papiuary raieroesreionma of the thy- roid predicting factors of lateral neck node metsstasis [ J ]. Ann surg Oneol,2009,16 (5) : 1348-1355.
  • 7ITO Y ,MIYAUCHI A . Therapeutic strategies for papillary microcarci- noma of the thyroid [ J ]. Current Cancer Therapy Reviews. 2005,1 : 19 -25.
  • 8Kwait JY, Kim EK, Kim M J, et al, Papiuary raieroesreionma of the thy- roidpredicting factors of lateral neck node metsstasis [ J ]. Ann surg Oneol, 2009,16 ( 5 ) : 1348 - 1355.
  • 9Mcleod DS, Sawka AM, Cooper DS. Controversies in primary treat- ment of low-rlsk papillary thyroid cancer[ J]. Lancer, 2013, 381 (9871) : 1046-1057.
  • 10Hassanain M, Wexler M. Conservative management of well-differenti- ated thyroid cancer[J]. Can J Surg, 2010, 53(2) : 109-118.

引证文献13

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部